Navigation Links
Global Med Technologies(R) Licenses Transfusion Software Solution to Nationwide Healthcare System
Date:6/16/2009

40+ Hospital Organization Serves Growing Non-Urban Market Segments

DENVER, June 16 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international healthcare information technology company, today announced that its Wyndgate Technologies(R) division has licensed its SafeTrace Tx(R) transfusion management software to a 40+ hospital healthcare system. The organization will also be contracting validation services, another cost-effective business solution, from Global Med's PeopleMed subsidiary. Terms of the agreement were not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

SafeTrace Tx is transfusion management software which provides comprehensive tracking of orders, specimens, blood products, derivatives, and accessories with a complete testing and transfusion history in one consolidated record. These powerful features will assist the hospital healthcare system's staff in selecting appropriate blood products for their patients and help to reduce waste and increase efficiency in their blood banks.

Thomas F. Marcinek, President and COO of Global Med Technologies, Inc., stated, "Large healthcare organizations, both domestically and internationally, are increasingly selecting Global Med companies as their vendor of choice. We believe this is a result of several positive factors: Global Med's ability to meet the needs of our customers, our reputation, financial stability, and capacity to partner valued relationships with top laboratory and hospital information system vendors."

Mr. Marcinek continued, "We are pleased to have been chosen by this growing organization to implement our SafeTrace Tx transfusion management system in their hospitals. We appreciate their confidence in our ability to deliver quality business solutions and to develop a streamlined implementation plan."

About Global Med Technologies(R), Inc.

Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med's products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites.

Global Med's domestic companies are Wyndgate Technologies(R), a leader in software products and services for donor centers and hospital transfusion services; eDonor(R), which offers web-based donor relationship management systems; and PeopleMed(TM), Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.

Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.

For more information about Global Med's products and services, please call 800-996-3428 or visit www.globalmedtech.com.

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.


'/>"/>
SOURCE Global Med Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Global network formed to improve hearing implant outcomes
2. Health research agencies form global alliance to curb humanitys most fatal diseases
3. GlobalEquityReport.com Issues Cancer Stocks On The Move Today: HEB, GNBT, CTIC, CTHP, DNDN
4. Polycom and AMD Global Telemedicine Inc. To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On-The-Go
5. Hitting the Gym on the Web - a New Global Exercise Trend
6. Astellas Names Head of Global R&D Operations
7. Covance to Present at Goldman Sachs Thirtieth Annual Global Healthcare Conference
8. Tech Global Price Rollback on their 22" Dell Touch Screen Monitor
9. Amgen to Present at the Goldman Sachs Global Healthcare Conference
10. Companion Global Healthcare Inc. Offers Additional Hospital Choices to Employers, Individuals Looking to Save on Fully Credentialed Health Care
11. Otix Global, Inc. to Become Parent Company of Sonic Innovations, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... Semrock’s highly popular SearchLight Spectra Viewer ... resource for fluorescence microscopists and optical system designers, enabling The Right Solution, Right ... the globe, SearchLight has become a tremendously popular tool for the fluorescence imaging ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
(Date:4/26/2017)... , ... April 26, 2017 , ... Journal of ... It can have severe consequences to overall dental health, including complications with speech, eating, ... turn to dental implants to replace lost teeth. As the number of tooth replacements ...
(Date:4/26/2017)... ... April 26, 2017 , ... The ... Excellence upon National Registry of Emergency Medical Technicians and welcomes this ... said Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: